Article Cited by others

PERSPECTIVE

Therapeutic prevention of colorectal carcinogenesis

Meyskens Frank L

Year : 2011| Volume: 10| Issue : 1 | Page no: 13-13

   This article has been cited by
 
1 Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer
Rial, N.S. and Zell, J.A. and Cohen, A.M. and Gerner, E.W.
Expert Review of Gastroenterology and Hepatology. 2012; 6(4): 507-517
[Pubmed]  [Google Scholar]
2 Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer
Nathaniel S Rial,Jason A Zell,Alfred M Cohen,Eugene W Gerner
Expert Review of Gastroenterology & Hepatology. 2012; 6(4): 507
[Pubmed]  [Google Scholar] [DOI]

 

Read this article